Production (Stage)
MedMira Inc.
MIR.V
TSX
| 04/30/2025 | 01/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -14.40% | 7.52% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -14.40% | 7.52% | |||
| Cost of Revenue | -9.34% | -9.26% | |||
| Gross Profit | 7.17% | 14.97% | |||
| SG&A Expenses | -33.85% | 0.87% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -32.29% | -0.09% | |||
| Operating Income | 33.42% | 0.53% | |||
| Income Before Tax | 18.06% | 11.35% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 18.06% | 11.35% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 18.06% | 11.35% | |||
| EBIT | 33.42% | 0.53% | |||
| EBITDA | 36.03% | 0.28% | |||
| EPS Basic | 16.67% | 14.29% | |||
| Normalized Basic EPS | 25.00% | 0.00% | |||
| EPS Diluted | 28.57% | 6.67% | |||
| Normalized Diluted EPS | 25.00% | 0.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||